Skip to main content

Advertisement

Table 2 Efficacy Analysis (ANCOVA)

From: A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

Endpoint Coefficient ± Std Err p-value
GSRS: Abdominal Pain Subscore (lower is better) -0.627 ± 0.307 0.046 †
GSRS: Abdominal Distension Subscore (lower is better) -0.572 ± 0.299 0.061 ‡
GSRS: Increased Flatus Subscore (lower is better) -0.511 ± 0.353 0.154
GSRS: Total Score (lower is better) -4.806 ± 2.381 0.048 †
SODA: Bloating Subscore (lower is better) -0.229 ± 0.216 0.294
SODA: Gas Subscore (lower is better) -0.348 ± 0.219 0.118
SODA: Non-Pain Symptoms Score (lower is better) -1.025 ± 0.870 0.244
SODA: Satisfaction Score (lower is better) -0.058 ± 1.358 0.966
SF-36v2: Physical Component Summary (higher is better) 0.941 ± 1.118 0.403
SF-36v2: Mental Component Summary (higher is better) -2.400 ± 2.010 0.238
  1. † Significant (p ≤ 0.05)
  2. ‡Approaches significance (p ~ 0.05)